VIDEO: New oral anticoagulants cut intracranial bleeds in real-world atrial fib patients

During the first year on anticoagulant treatment, patients who received a new oral anticoagulant (NOAC) had an ischemic stroke rate similar to that of patients who received the traditional oral anticoagulant, warfarin. But they also had a significantly reduced rate of intracranial hemorrhage, according to Laila Stærk, MD, who reported on the findings at the annual congress of the European Society of Cardiology. The study included 43,299 Danish patients, of which 42% received warfarin, 29% received dabigatran, 16% received apixaban, and 13% received rivaroxaban. More on the results of this study are available in this article and video from Cardiology News : http://www.ecardiologynews.com/specialty-focus/arrhythmias-electrophysiology/single-article-page/video-noacs-cut-intracranial-bleeds-in-real-world-atrial-fib-patients/2c213686c34e2f2e9fb58000ff2cad80.html.